178 related articles for article (PubMed ID: 32955822)
21. High-risk cutaneous squamous cell carcinoma.
Nuño-González A; Vicente-Martín FJ; Pinedo-Moraleda F; López-Estebaranz JL
Actas Dermosifiliogr; 2012 Sep; 103(7):567-78. PubMed ID: 22261673
[TBL] [Abstract][Full Text] [Related]
22. Guidelines of care for the management of cutaneous squamous cell carcinoma.
; ; Kim JYS; Kozlow JH; Mittal B; Moyer J; Olenecki T; Rodgers P
J Am Acad Dermatol; 2018 Mar; 78(3):560-578. PubMed ID: 29331386
[TBL] [Abstract][Full Text] [Related]
23. Molecular and immune targets in cutaneous squamous cell carcinoma.
Galambus J; Tsai KY
Mol Carcinog; 2023 Jan; 62(1):38-51. PubMed ID: 36000298
[TBL] [Abstract][Full Text] [Related]
24. Review of systemic agents in the treatment of advanced cutaneous squamous cell carcinoma.
Petersen ET; Ahmed SR; Chen L; Silapunt S; Migden MR
Future Oncol; 2019 Sep; 15(27):3171-3184. PubMed ID: 31382778
[TBL] [Abstract][Full Text] [Related]
25. Systemic Therapy in Advanced Cutaneous Squamous Cell Carcinoma (CSCC): The Roswell Park Experience and a Review of the Literature.
Jarkowski A; Hare R; Loud P; Skitzki JJ; Kane JM; May KS; Zeitouni NC; Nestico J; Vona KL; Groman A; Khushalani NI
Am J Clin Oncol; 2016 Dec; 39(6):545-548. PubMed ID: 24879468
[TBL] [Abstract][Full Text] [Related]
26. Systemic therapy for advanced cutaneous squamous cell carcinoma.
Fitzgerald K; Tsai KK
Semin Cutan Med Surg; 2019 Mar; 38(1):E67-E74. PubMed ID: 31051028
[TBL] [Abstract][Full Text] [Related]
27. Fibroblast growth factor receptor promotes progression of cutaneous squamous cell carcinoma.
Khandelwal AR; Kent B; Hillary S; Alam MM; Ma X; Gu X; DiGiovanni J; Nathan CO
Mol Carcinog; 2019 Oct; 58(10):1715-1725. PubMed ID: 31254372
[TBL] [Abstract][Full Text] [Related]
28. Advanced cutaneous squamous cell carcinoma: real world data of patient profiles and treatment patterns.
Amaral T; Osewold M; Presser D; Meiwes A; Garbe C; Leiter U
J Eur Acad Dermatol Venereol; 2019 Dec; 33 Suppl 8():44-51. PubMed ID: 31658392
[TBL] [Abstract][Full Text] [Related]
29. Systemic treatment of patients with advanced cutaneous squamous cell carcinoma: response rates and outcomes of the regimes used.
Ogata D; Namikawa K; Otsuka M; Asai J; Kato H; Yasuda M; Maekawa T; Fujimura T; Kato J; Takenouchi T; Nagase K; Kawaguchi M; Kaji T; Kuwatsuka Y; Shibayama Y; Takai T; Okumura M; Kambayashi Y; Yoshikawa S; Yamazaki N; Tsuchida T
Eur J Cancer; 2020 Mar; 127():108-117. PubMed ID: 32004792
[TBL] [Abstract][Full Text] [Related]
30. Overview of guideline recommendations for the management of high-risk and advanced cutaneous squamous cell carcinoma.
Dessinioti C; Stratigos AJ
J Eur Acad Dermatol Venereol; 2022 Jan; 36 Suppl 1():11-18. PubMed ID: 34855249
[TBL] [Abstract][Full Text] [Related]
31. Metastatic cutaneous squamous cell carcinoma treated successfully with surgery, radiotherapy and S-1/cisplatin chemotherapy.
Matsushita S; Kawai K; Tada K; Mera K; Kubo H; Ibusuki A; Yoshii N; Kanekura T
J Dermatol; 2010 Jul; 37(7):666-70. PubMed ID: 20629834
[TBL] [Abstract][Full Text] [Related]
32. New perspectives on role of tumor microenvironment in progression of cutaneous squamous cell carcinoma.
Nissinen L; Farshchian M; Riihilä P; Kähäri VM
Cell Tissue Res; 2016 Sep; 365(3):691-702. PubMed ID: 27411692
[TBL] [Abstract][Full Text] [Related]
33. Telomeres and Telomerase in Cutaneous Squamous Cell Carcinoma.
Ventura A; Pellegrini C; Cardelli L; Rocco T; Ciciarelli V; Peris K; Fargnoli MC
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30884806
[TBL] [Abstract][Full Text] [Related]
34. Molecular prediction of metastasis in cutaneous squamous cell carcinoma.
Mulvaney PM; Schmults CD
Curr Opin Oncol; 2020 Mar; 32(2):129-136. PubMed ID: 31850970
[TBL] [Abstract][Full Text] [Related]
35. Association of Disease Recurrence With Survival Outcomes in Patients With Cutaneous Squamous Cell Carcinoma of the Head and Neck Treated With Multimodality Therapy.
Sun L; Chin RI; Gastman B; Thorstad W; Yom SS; Reddy CA; Nussenbaum B; Wang SJ; Knackstedt T; Vidimos AT; Koyfman SA; Manyam BV
JAMA Dermatol; 2019 Apr; 155(4):442-447. PubMed ID: 30810715
[TBL] [Abstract][Full Text] [Related]
36. A multi-institutional comparison of outcomes of immunosuppressed and immunocompetent patients treated with surgery and radiation therapy for cutaneous squamous cell carcinoma of the head and neck.
Manyam BV; Garsa AA; Chin RI; Reddy CA; Gastman B; Thorstad W; Yom SS; Nussenbaum B; Wang SJ; Vidimos AT; Koyfman SA
Cancer; 2017 Jun; 123(11):2054-2060. PubMed ID: 28171708
[TBL] [Abstract][Full Text] [Related]
37. Advances in cutaneous squamous cell carcinoma.
Winge MCG; Kellman LN; Guo K; Tang JY; Swetter SM; Aasi SZ; Sarin KY; Chang ALS; Khavari PA
Nat Rev Cancer; 2023 Jul; 23(7):430-449. PubMed ID: 37286893
[TBL] [Abstract][Full Text] [Related]
38. Update on the anti-programmed cell death-1 receptor antibodies in advanced cutaneous squamous-cell carcinoma.
Benzaquen M
Dermatol Ther; 2020 May; 33(3):e13325. PubMed ID: 32208547
[TBL] [Abstract][Full Text] [Related]
39. Chemoradiotherapy could improve overall survival of patients with stage IV cutaneous squamous cell carcinoma: analysis of 34 cases.
Hiura A; Yoshino K; Maeda T; Nagai K; Oaku S; Kato M; Fujisawa Y
Br J Dermatol; 2019 Jun; 180(6):1557-1558. PubMed ID: 30791086
[No Abstract] [Full Text] [Related]
40. Cutaneous Squamous Cell Carcinoma.
Parekh V; Seykora JT
Clin Lab Med; 2017 Sep; 37(3):503-525. PubMed ID: 28802498
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
